Karyopharm Therapeutics Inc (FRA:25K)
€ 0.5734 -0.0194 (-3.27%) Market Cap: 84.88 Mil Enterprise Value: 143.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Karyopharm Therapeutics Inc Annual Shareholders Meeting Transcript

May 21, 2021 / 01:00PM GMT
Release Date Price: €7.97 (+3.29%)
Operator

Good morning, and welcome to Karyopharm Therapeutics, Inc. 2021 Annual Meeting of Stockholders.

I would now like to introduce Richard Paulson, Karyopharm's President and Chief Executive Officer.

Richard A. Paulson
Karyopharm Therapeutics Inc. - President, CEO & Director

Good afternoon. I am Richard Paulson, President and Chief Executive Officer and a Director of Karyopharm Therapeutics. I would like to welcome you all to the Karyopharm 2020 (sic) [2021] Annual Meeting of Stockholders. We have chosen to hold our annual meeting this year as a virtual meeting in order to better support the health and well-being of our stockholders, employees and directors in light of the COVID-19 pandemic, and we welcome you to this live webcast. We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting.

It is now 9:00 a.m. Eastern Time on the 21st day of May 2021, and I call this meeting to order. I will be serving as chairman of today's meeting, and I've asked Michael Mano,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot